According to a High-Level Panel convened to advise the UN Secretary-General on improving access to medicines, the world must take bold new approaches to both health technology innovation and ensuring access so that all people can benefit from the medical advances that have dramatically improved the lives of millions around the world in the last century. 

The UN Secretary-General established the High-Level Panel to propose solutions for addressing the incoherencies between international human rights, trade, intellectual property rights and public health objectives.

The report recommendations come at the end of a ten-month process for the Panel under the leadership of Ruth Dreifuss and the former President of the Swiss Confederation and Festus Mogae, the former President of the Republic of Botswana.  

Hundreds of millions people living with NCDs in low- and middle-income countries (LMICs) are dying prematurely or suffering life threatening complications because they cannot access affordable and essential NCD medicines and technologies.

Many of these lifesaving medicines are proven to work and cost just cents to produce. We have the medicines and technologies to save lives, but international funding is not available in LMICs.

Funding for NCD medicines and technologies is critical for both treatment and prevention. Simple medicines given early can prevent or delay the onset of many NCDs and prevent secondary complications that cost lives, throw families into destitution and impose huge costs on vulnerable health systems.

Download full report via the link below.